• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 443085 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1416850411 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1416850411 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Shares of Masimo Are Moving Lower on 1.9x Above-Average Volume (MASI)

Published on Fri, 02/15/2013 - 14:11
By Robert Cotter

Shares of Masimo are trading today in above average volume, with the share price falling 1.2% to $19.99. About 793,000 shares have been traded today, as compared to the 30-day average volume of 428,000 shares. Spikes in volume can validate a breakout or signify a potential turning point.

There is potential upside of 36.7% for shares of Masimo based on a current price of $19.99 and an average consensus analyst price target of $27.33. Masimo shares should first meet resistance at the 50-day moving average (MA) of $20.53 and find additional resistance at the 200-day MA of $21.51.

In the past 52 weeks, shares of Masimo have traded between a low of $17.62 and a high of $35.15 and are now at $19.99, which is 13% above that low price. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.2% while the 200-day MA has slid 0.2%.

Masimo Corporation designs, develops and licenses medical signal processing and sensor technology for the noninvasive monitoring of physiological parameters. The Company's first products are designed to improve the effectiveness of pulse oximetry by overcoming the inability of current monitors to precisely measure the levels of arterial blood oxygen saturation and low arterial blood flow.

By Robert Cotter
rcotter@fnno.com

Latest News from FNNO

Team Shares Climbing Higher, Up 1.8%...

One of today's stocks on the move is Team (NASDAQ:TISI), up 1.8% to $41.45. The Dow Jo ...

Stock Investors Sell Off Shares of Franc...

One of today's notable stocks in decline is Franco-Nevada (NYSE:FNV), down 1.8% to $53. ...

Finish Line Shares Climbing Higher, Up 1...

Finish Line (NASDAQ:FINL) is a company whose shares are active, trading 1.8% higher to ...

Buyers Accumulate Shares of Banco Bilbao...

Banco Bilbao Vizcaya Argentaria (NYSE:BBVA) is one of today's notable stocks on the ris ...

Bank of the Ozarks Shares Climbing Highe...

Up 1.8% to $35.98, Bank of the Ozarks (NASDAQ:OZRK), is one of today's notable movers. ...

Buyers Accumulate Shares of Incyte, Up 1...

Incyte (NASDAQ:INCY) is one of today's notable stocks on the rise, up 1.8% to $73.60. ...

Auxilium Pharmaceuticals Makes a Move: U...

Auxilium Pharmaceuticals (NASDAQ:AUXL), a company whose shares are moving quickly, is t ...

Reed's Shares Climbing Higher, Up 1.9%...

Reed's (NYSE:REED) is a company whose shares are active, trading 1.9% higher to $6.60. ...